For fiscal 2010, CPW net sales grew by 6 percent due to 4 per- centage points of growth from net price realization and mix, 1 per- centage point from favorable foreign exchange and a 1 percentage point increase in volume, including growth in Russia, Southeast Asia, the Middle East and Latin America. Net sales for HDJ decreased 4 percent from fiscal 2009 due to an 11 percentage point decline in volume, partially offset by favorable foreign exchange. CPW reclassified certain expenses as a reduction to net sales. To conform to the current period presentation, CPW reduced its pre- viously reported net sales by approximately $150 million in fiscal 2009 and $200 million in 2008. There was no effect on after-tax earnings from joint ventures in our Consolidated Statements of Earnings. For fiscal 2009, CPW net sales grew by 5 percent reflecting higher volume and net price realization, slightly offset by unfa- vorable foreign currency exchange. Net sales for HDJ increased 2 percent from fiscal 2008 as a result of favorable foreign exchange of 11 percentage points and positive net price realiza- tion, offset by a decrease in volume. Selected cash flows from our joint ventures are set forth in the following table: The primary source of our liquidity is cash flow from operations. Over the most recent three-year period, our operations have generated $5.7 billion in cash. A substantial portion of this oper- ating cash flow has been returned to stockholders through share repurchases and dividends. We also use this source of liquidity to fund our capital expenditures. We typically use a combination of cash, notes payable, and long-term debt to finance acquisitions and major capital expansions. codifies health care reforms with staggered effective dates from 2010 to 2018. Many provisions in the Act require the issuance of additional guidance from various government agencies. Because the Act does not take effect fully until future years, we do not expect the Act to have a material impact on our fiscal 2011 results of operations. Given the complexity of the Act, the extended time period over which the reforms will be implemented, and the unknown impact of future regulatory guidance, the full impact of the Act on future periods will not be known until those reg- ulations are adopted. We have experienced significant input cost volatility since fiscal 2006. Our gross margin performance in fiscal 2010 reflects the impact of modest input cost deflation, primarily on commodities inputs, following three consecutive years of significant input cost inflation. We expect the cost of commodities and energy to increase in fiscal 2011. We attempt to minimize the effects of inflation through planning and operating practices. Our risk man- agement practices are discussed on pages 42 through 44 of this report. The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, the Act) was signed into law in March 2010. The Act IMPACT OF INFLATION 30 General Mills Selected Cash Flows from Joint Ventures LIQUIDITY Inflow (Outflow), in Millions 2010 2009 2008 Fiscal Year ................................................................... ......................................................................................................................................................................................... Advances to joint ventures $(131.0) $(14.2) $ (20.6) Repayments of advances 2.9 22.4 95.8 Dividends received 88.0 68.5 108.7